VeriMom¿Es lavandula angustifolia flower oil seguro durante el embarazo?
No EU Annex II/III listing or harmonised CLP classification was found (no H360/H361/H codes). Case reports and in vitro assays report estrogenic/anti‑androgenic activity linked to lavender oil components (Henley NEJM 2007; J Clin Endocrinol Metab review), but a well‑conducted in vivo uterotrophic percutaneous assay in immature rats found no estrogenic activity (Politano et al. 2013). Overall this places hazard at a low/theoretical level (h=1) with demonstrated in vitro mechanism evidence (m=2). Topical cosmetic exposure gives low but measurable systemic exposure (e=1). Sources: Henley 2007 (NEJM), J Clin Endocrinol Metab case series/assays, Politano 2013 uterotrophic negative, ECHA substance records, EWG entry.
Alternativas seguras a lavandula angustifolia flower oil en el embarazo | VeriMom
Related ingredients
Frequently asked questions
- ¿Es lavandula angustifolia flower oil seguro durante el embarazo?
- No EU Annex II/III listing or harmonised CLP classification was found (no H360/H361/H codes). Case reports and in vitro assays report estrogenic/anti‑androgenic activity linked to lavender oil components (Henley NEJM 2007; J Clin Endocrinol Metab review), but a well‑conducted in vivo uterotrophic percutaneous assay in immature rats found no estrogenic activity (Politano et al. 2013). Overall this places hazard at a low/theoretical level (h=1) with demonstrated in vitro mechanism evidence (m=2). Topical cosmetic exposure gives low but measurable systemic exposure (e=1). Sources: Henley 2007 (NEJM), J Clin Endocrinol Metab case series/assays, Politano 2013 uterotrophic negative, ECHA substance records, EWG entry.
- ¿Es lavandula angustifolia flower oil seguro durante la lactancia?
- Same rationale as pregnancy: no harmonised classification or regulatory ban; mechanistic/in vitro signals exist but in vivo data do not confirm estrogenicity. Systemic absorption from topical use is low, so maternal exposure and transfer into breastmilk are possible but expected to be low from normal cosmetic use; therefore h=1, m=2, e=1.
- ¿Es lavandula angustifolia flower oil seguro para la piel del bebé?
- Hazard remains low/theoretical (h=1) because human case reports/in vitro activity exist but no harmonised classification or conclusive animal reproductive/teratogenic evidence. Mechanistic signals (estrogenic/anti‑androgenic activity in vitro) are documented (m=2). Exposure score is increased by +1 for infants (immature skin barrier, higher surface-to-weight ratio) giving e=2 for baby topical exposure. Additionally, lavender oil constituents (oxidized linalool) are recognised contact allergens—relevance for infant skin sensitization is separate from reproductive scoring.
- ¿Cómo puntúa VeriMom a lavandula angustifolia flower oil?
- VeriMom puntúa lavandula angustifolia flower oil en 60/100 (riesgo medio) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a lavandula angustifolia flower oil en el embarazo?
- Consulta nuestra lista de alternativas seguras a lavandula angustifolia flower oil según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.